IND Application Fast Facts

Posted 06 January 2017 By Valerie Fauvelle

placeholder+image This article provides information companies need when filing an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to help make the application process more efficient. It addresses common questions and concerns that develop across multiple companies and multidisciplinary groups.

Share this article:

Categories: Biologics and biotechnology, Drugs, Clinical, Preclinical, Submission and registration, Features, US, FDA

Tags: IND, Investigational New Drug Application

Regulatory Exchange: Latest Updates From the Community